Actively Managed Equity
Overview: All Strategies
Investor Resources
Indexed Equity
Private Equity
Digital Assets
Invest In The Future Today
Take Advantage Of Market Inefficiencies
Make The World A Better Place
Articles
Podcasts
White Papers
Newsletters
Videos
The Bitcoin Monthly
Big Ideas 2024
Search Results For
Result: NaN items
Page Results
Investment Strategy
Found: 5 items
Articles
Found: 38 items
Understanding DNA, the Human Genome, and the Rise of CRISPR
The Exploitable Genomics of Cancer: Earlier Cancer Detection Part II
White papers
Found: 2 items
Podcasts
Found: 22 items
Videos
Found: 4 items
Not Your Traditional Investment Firm
ARK is an investment manager focused solely on disruptive innovation. Rooted in over 40 years of experience, we aim to identify large-scale investment opportunities in the public markets resulting from technological innovations centered around DNA sequencing, robotics, energy storage, artificial intelligence, and blockchain technology. Learn why we believe innovation is key to growth and what sets us apart from other investment firms.
BIS2022 - Gene Editing: Curing Disease, Not Masking Symptoms
The convergence of next generation DNA sequencing, CRISPR gene-editing, and artificial intelligence (AI) has the potential to transform health care. These advances could accelerate the pace of scientific discovery, personalizing medicine to cure disease instead of masking symptoms.